Top

European Journal of Clinical Microbiology & Infectious Diseases

Published in:

01-11-2021 | Fosfomycin | Brief Report

Role of asymptomatic bacteriuria on early periprosthetic joint infection after hip hemiarthroplasty. BARIFER randomized clinical trial

Authors: Dolors Rodríguez-Pardo, María Dolores del Toro, Laura Guío-Carrión, Rosa Escudero-Sánchez, Marta Fernández-Sampedro, Miguel Ángel García-Viejo, María Velasco-Arribas, Laura Soldevila-Boixader, Magdalena Femenias, José Antonio Iribarren, María del Carmen Pulido-Garcia, María Dolores Navarro, Mayli Lung, Pablo S. Corona, Benito Almirante, Carles Pigrau

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 11/2021

Abstract

Purpose

To evaluate preoperative asymptomatic bacteriuria (ASB) treatment to reduce early-periprosthetic joint infections (early-PJIs) after hip hemiarthroplasty (HHA) for fracture.

Methods

Open-label, multicenter RCT comparing fosfomycin-trometamol versus no intervention with a parallel follow-up cohort without ASB. Primary outcome: early-PJI after HHA.

Results

Five hundred ninety-four patients enrolled (mean age 84.3); 152(25%) with ASB (77 treated with fosfomycin-trometamol/75 controls) and 442(75%) without. Despite the study closed without the intended sample size, ASB was not predictive of early-PJI (OR: 1.06 [95%CI: 0.33–3.38]), and its treatment did not modify early-PJI incidence (OR: 1.03 [95%CI: 0.15–7.10]).

Conclusions

Neither preoperative ASB nor its treatment appears to be risk factors of early-PJI after HHA. ClinicalTrials.gov Identifier: Eudra CT 2016-001108-47

Available only for authorised users

Edwards C, Counsell A, Boulton C, Moran CG (2008) Early infection after hip fracture surgery. J Bone Jt Surg Ser B 90:770–777. https://doi.org/10.1302/0301-620X.90B6.20194CrossRef

Cordero-Ampuero J, De Dios M (2010) What are the risk factors for infection in hemiarthroplasties and total hip arthroplasties? Clin Orthop Relat Res 468:3268–3277. https://doi.org/10.1007/s11999-010-1411-8CrossRefPubMedPubMedCentral

Phillips JRA, Moran CG, Manktelow ARJ (2013) Periprosthetic fractures around hip hemiarthroplasty performed for hip fracture. Injury 44:757–762. https://doi.org/10.1016/j.injury.2012.09.015CrossRefPubMed

Gallardo-Calero I, Larrainzar-Coghen T, Rodriguez-Pardo D, Pigrau C, Sánchez-Raya J, Amat C et al (2016) Increased infection risk after hip hemiarthroplasty in institutionalized patients with proximal femur fracture. Injury 47. https://doi.org/10.1016/j.injury.2015.12.032

Vigilància de la infecció nosocomial als hospitals de Catalunya (VINCat), informe 2017. https://catsalut.gencat.cat/web/.content/minisite/vincat/documents/informes/informe-2017.pdf

Nicolle LE, Gupta K, Bradley SF, Colgan R, DeMuri GP, Drekonja D et al (2019) Clinical practice guideline for the management of asymptomatic bacteriuria: 2019 update by the Infectious Diseases Society of Americaa. Clin Infect Dis 68:1611–1615. https://doi.org/10.1093/cid/ciz021CrossRefPubMed

Sousa R, Muñoz-Mahamud E, Quayle J, Da Costa LD, Casals C, Scott P et al (2014) Is asymptomatic bacteriuria a risk factor for prosthetic joint infection? Clin Infect Dis 59:41–47. https://doi.org/10.1093/cid/ciu235CrossRefPubMedPubMedCentral

Cordero-Ampuero J, González-Fernández E, Martínez-Vélez D, Esteban J (2013) Are antibiotics necessary in hip arthroplasty with asymptomatic bacteriuria? Seeding risk with/without treatment. Clin Orthop Relat Res 471:3822–3829. https://doi.org/10.1007/s11999-013-2868-zCrossRefPubMedPubMedCentral

Drekonja DM, Zarmbinski B, Johnson JR (2013) Preoperative urine cultures at a veterans affairs medical center. JAMA Intern Med 173:71. https://doi.org/10.1001/2013.jamainternmed.834CrossRefPubMed

10.

Bouvet C, Lübbeke A, Bandi C, Pagani L, Stern R, Hoffmeyer P, et al. (2014) Is there any benefit in pre-operative urinary analysis before elective total joint replacement? Bone Joint J [cited 2021 14];96-B:390–4. https://pubmed.ncbi.nlm.nih.gov/24589797/. https://doi.org/10.1302/0301-620x.96b3.32620

11.

Mayne AIW, Davies PSE, Simpson JM (2018) Antibiotic treatment of asymptomatic bacteriuria prior to hip and knee arthroplasty; a systematic review of the literature. Surgeon [cited 2021 14];16:176–82. https://pubmed.ncbi.nlm.nih.gov/29174023/. https://doi.org/10.1016/j.surge.2017.08.007

12.

Langenhan R, Bushuven S, Reimers N, Probst A (2018) Peri-operative antibiotic treatment of bacteriuria reduces early deep surgical site infections in geriatric patients with proximal femur fracture. Int. Orthop [cited 2021 14];42:741–6. https://pubmed.ncbi.nlm.nih.gov/29224055/. https://doi.org/10.1007/s00264-017-3708-7

13.

Moher D, Schulz KF, Altman DG, Lepage L (2001) The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Ann Intern Med 134:657–662. https://doi.org/10.7326/0003-4819-134-8-200104170-00011CrossRefPubMed

14.

Zimmerli W, Trampuz A, Ochsner PE (2004) Current concepts: prosthetic-joint infections. N Engl J Med 351:1645–1654. https://doi.org/10.1056/NEJMra040181CrossRefPubMed

15.

Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM et al (2013) Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 56:e1–e25. https://doi.org/10.1093/cid/cis803

16.

Glynn MKSJ (1984) The significance of asymptomatic bacteriuria in patients undergoing hip/knee arthroplasty. Clin Orthop Relat Res 185:151–154

17.

David TS, Vrahas MS (2000) Perioperative lower urinary tract infections and deep sepsis in patients undergoing total joint arthroplasty. J Am Acad Orthop Surg 8:66–74. https://doi.org/10.5435/00124635-200001000-00007CrossRefPubMed

18.

Rajamanickam A, Noor S, Usmani A (2007) Should an asymptomatic patient with an abnormal urinalysis (bacteriuria or pyuria) be treated with antibiotics prior to major joint replacement surgery? Cleve Clin J Med 74:17–18. https://doi.org/10.3949/ccjm.74.Electronic_Suppl_1.S17CrossRef

19.

Otermin I, Rivero M, Hidalgo Á (2009) Es necesario retrasar o suspender la cirugía en el caso de una posible bacteriuria asintomática? ¿y una cirugía con implantes en ortopedia? Enferm Infecc Microbiol Clin 27:252–253. https://doi.org/10.1016/j.eimc.2008.03.005CrossRefPubMed

20.

Nicolle L (2019) Symptomatic urinary tract infection or asymptomatic bacteriuria? Improving care for the elderly. Clin Microbiol Infect 25:779–781. https://doi.org/10.1016/j.cmi.2019.03.013CrossRefPubMed

21.

Bosch-Nicolau P, Falcó V, Viñado B, Andreu A, Len O, Almirante B et al (2017) A cohort study of risk factors that influence empirical treatment of patients with acute pyelonephritis. Antimicrob Agents Chemother 61:1–11. https://doi.org/10.1128/AAC.01317-17CrossRef

22.

Falagas ME, Kastoris AC, Kapaskelis AM, Karageorgopoulos DE (2010) Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum β-lactamase producing, Enterobacteriaceae infections: a systematic review. Lancet Infect Dis 10:43–50. https://doi.org/10.1016/S1473-3099(09)70325-1CrossRefPubMed

23.

Patel SS, Balfour JA, Bryson HM (1997) Fosfomycin Tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections. Drugs 53:637–656. https://doi.org/10.2165/00003495-199753040-00007CrossRefPubMed

24.

Sousa RJG, Abreu MA, Wouthuyzen-Bakker M, Soriano AV (2019) Is routine urinary screening indicated prior to elective total joint arthroplasty? A systematic review and meta-analysis. J Arthroplast 34:1523–1530. https://doi.org/10.1016/j.arth.2019.03.034CrossRef

25.

Sprowson AP, Jensen C, Chambers S, Parsons NR, Aradhyula NM, Carluke I et al (2016) The use of high-dose dual-impregnated antibiotic-laden cement with hemiarthroplasty for the treatment of a fracture of the hip the fractured hip infection trial. Bone Jt J 98-B:1534–1541. https://doi.org/10.1302/0301-620X.98B11.34693CrossRef

26.

Jameson SS, Jensen CD, Elson DW et al (2013) Cemented versus cementless hemiar- throplasty for intracapsular neck of femur fracture--a comparison of 60,848 matched patients using national data. Injury 44:730–734CrossRef

27.

Middleton RG, Uzoigwe CE, Young PS et al (2014) Peri-operative mortality after hemi- arthroplasty for fracture of the hip: does cement make a difference? Bone Jt J 96-B:1185–1191CrossRef

28.

Barbero JM, Montero E, Vallés A, Plasencia MA, Romanyk J, Gómez J (2016) Prosthetic joint infection in patients with hip fracture. Differences from infection of elective prosthesis. Rev Esp Quimioter 29:273–277PubMed

29.

Nicolle LE, Bradley S, Colgan R, Rice JC, Schaeffer A, Hooton TM (2005) Infectious diseases society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis 40:643–654. https://doi.org/10.1086/427507CrossRefPubMed

Title: Role of asymptomatic bacteriuria on early periprosthetic joint infection after hip hemiarthroplasty. BARIFER randomized clinical trial
Authors: Dolors Rodríguez-Pardo
María Dolores del Toro
Laura Guío-Carrión
Rosa Escudero-Sánchez
Marta Fernández-Sampedro
Miguel Ángel García-Viejo
María Velasco-Arribas
Laura Soldevila-Boixader
Magdalena Femenias
José Antonio Iribarren
María del Carmen Pulido-Garcia
María Dolores Navarro
Mayli Lung
Pablo S. Corona
Benito Almirante
Carles Pigrau
Publication date: 01-11-2021
Publisher: Springer Berlin Heidelberg
Keywords: Fosfomycin
Joint Infection
Published in: European Journal of Clinical Microbiology & Infectious Diseases / Issue 11/2021
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI: https://doi.org/10.1007/s10096-021-04241-2

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Role of asymptomatic bacteriuria on early periprosthetic joint infection after hip hemiarthroplasty. BARIFER randomized clinical trial

Abstract

Purpose

Methods

Results

Conclusions

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 11/2021

Profiles of multidrug-resistant organisms among patients with bacteremia in intensive care units: an international ID-IRI survey

The road to success of coagulase-negative staphylococci: clinical significance of small colony variants and their pathogenic role in persistent infections

A comparison of E. coli susceptibility for amoxicillin/clavulanic acid according to EUCAST and CLSI guidelines

Combined selective culture and molecular methods for the detection of carbapenem-resistant organisms from fecal specimens

Prevalence and characteristics of persistent symptoms after non-severe COVID-19: a prospective cohort study

The impact of varicella vaccination on paediatric herpes zoster epidemiology: a Canadian population-based retrospective cohort study

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page